BACKGROUND: There is limited research to support the effect of exercise adherence on clinical outcomes in patients with heart failure (HF). This secondary analysis was conducted on the intervention arm of an exercise training study in patients with HF to assess whether adherence and the dose of treatment exposure were associated with clinical outcomes, functional performance (maximum oxygen consumption [VO2], anaerobic threshold, and workload), and quality of life (QOL). METHODS:Seventy-one patients (average age, 54 +/- 12.5 years; male, 66%; Caucasian, 66%; married, 61%; New York Heart Association class II-III, 97.2%; and average ejection fraction, 26.4% +/- 6.5%) were included in the current study. Patients with an increase >/= 18% in the amount of exercise from baseline to 6 months, as measured by pedometers, were categorized as adherers (n = 38); patients who had no change or an increase in the amount of exercise of <18% were categorized as nonadherers (n = 33). RESULTS: The 2 groups were significantly different in the composite endpoint of all-cause hospitalization, emergency room admissions, and death/urgent transplantation (hazard ratio, 0.31; 95% confidence interval, 0.159-0.635; P < 0.001). Adherers had greater improvements in functional performance and QOL compared with nonadherers (P< 0.001). CONCLUSION: These findings suggest that among patients with advanced HF, adherence to exercise is associated with more favorable clinical outcomes. There is also a positive dose-response relationship between the amount of exercise performed and improvement in functional performance and QOL.
RCT Entities:
BACKGROUND: There is limited research to support the effect of exercise adherence on clinical outcomes in patients with heart failure (HF). This secondary analysis was conducted on the intervention arm of an exercise training study in patients with HF to assess whether adherence and the dose of treatment exposure were associated with clinical outcomes, functional performance (maximum oxygen consumption [VO2], anaerobic threshold, and workload), and quality of life (QOL). METHODS: Seventy-one patients (average age, 54 +/- 12.5 years; male, 66%; Caucasian, 66%; married, 61%; New York Heart Association class II-III, 97.2%; and average ejection fraction, 26.4% +/- 6.5%) were included in the current study. Patients with an increase >/= 18% in the amount of exercise from baseline to 6 months, as measured by pedometers, were categorized as adherers (n = 38); patients who had no change or an increase in the amount of exercise of <18% were categorized as nonadherers (n = 33). RESULTS: The 2 groups were significantly different in the composite endpoint of all-cause hospitalization, emergency room admissions, and death/urgent transplantation (hazard ratio, 0.31; 95% confidence interval, 0.159-0.635; P < 0.001). Adherers had greater improvements in functional performance and QOL compared with nonadherers (P< 0.001). CONCLUSION: These findings suggest that among patients with advanced HF, adherence to exercise is associated with more favorable clinical outcomes. There is also a positive dose-response relationship between the amount of exercise performed and improvement in functional performance and QOL.
Authors: Ileana L Piña; Carl S Apstein; Gary J Balady; Romualdo Belardinelli; Bernard R Chaitman; Brian D Duscha; Barbara J Fletcher; Jerome L Fleg; Jonathan N Myers; Martin J Sullivan Journal: Circulation Date: 2003-03-04 Impact factor: 29.690
Authors: Robert S McKelvie; Koon K Teo; Robin Roberts; Neil McCartney; Dennis Humen; Terence Montague; Katie Hendrican; Salim Yusuf Journal: Am Heart J Date: 2002-07 Impact factor: 4.749
Authors: G C Fonarow; L W Stevenson; J A Walden; N A Livingston; A E Steimle; M A Hamilton; J Moriguchi; J H Tillisch; M A Woo Journal: J Am Coll Cardiol Date: 1997-09 Impact factor: 24.094
Authors: Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña Journal: JAMA Date: 2009-04-08 Impact factor: 56.272
Authors: Stephanie Tierney; Mamas Mamas; Stephen Woods; Martin K Rutter; Martin Gibson; Ludwig Neyses; Christi Deaton Journal: Heart Fail Rev Date: 2012-01 Impact factor: 4.214
Authors: Borja Del Pozo-Cruz; Graeme Carrick-Ranson; Stacey Reading; Paul Nolan; Lance C Dalleck Journal: Qual Life Res Date: 2018-01-19 Impact factor: 4.147
Authors: Windy W Alonso; Kevin A Kupzyk; Joseph F Norman; Scott W Lundgren; Alfred Fisher; Merry L Lindsey; Steven J Keteyian; Bunny J Pozehl Journal: J Card Fail Date: 2021-09-15 Impact factor: 5.712
Authors: Michael L Alosco; Mary Beth Spitznagel; Lindsay Miller; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad Journal: Health Psychol Date: 2012-08-27 Impact factor: 4.267
Authors: Lindsey Anderson; Georgina A Sharp; Rebecca J Norton; Hasnain Dalal; Sarah G Dean; Kate Jolly; Aynsley Cowie; Anna Zawada; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2017-06-30
Authors: Joseph F Norman; Kevin A Kupzyk; Nancy T Artinian; Steven J Keteyian; Windy S Alonso; Sara E Bills; Bunny J Pozehl Journal: Eur J Cardiovasc Nurs Date: 2019-08-02 Impact factor: 3.908
Authors: Rod S Taylor; Viral A Sagar; Ed J Davies; Simon Briscoe; Andrew J S Coats; Hayes Dalal; Fiona Lough; Karen Rees; Sally Singh Journal: Cochrane Database Syst Rev Date: 2014-04-27